CLINICAL AND IMMUNOLOGICAL EFFICACY OF THE RECOMBINANT INTERFERON alfa-2b OF ACUTE EPSTEIN-BARR VIRAL MONONUCLEOSIS IN PRESCHOOL CHILDREN

Conducted clinical and immunological examination of 51 children with acute Epstein-Barr viral mononucleosis (EBV) in age from 1 year to 7 years. All children diagnosed with a moderate degree of the disease. In the treatment of 25 people (comparison group) used the standard treatment (pathogenetic, symptomatic), treatment 26 people (main group) included the use as antiviral and immunotropic means of the preparation of human recombinant interferon Alfa-2b in the form of rectal suppositories — VIFERON®. The immunological survey was conducted in dynamics: at the height of the disease and in the convalescence period. The blood was determined indicators of cellular immunity (leukocytes, lymphocytes, CD3+, CD4+, CD8+, CD56+, HLAII+, CD95+, CD1 6+, CD25+), the concentration of IFN-a, IFN-y, IL-4 levels in spontaneous and induced production, in the serum). At milestones children of the main group noted rapid regression of clinical symptoms, normalization of body temperature, reducing intoxication, positive dynamics lymphoproliferative syndrome), a significant reduction in bed-days, no layering respiratory viral infections. Interferon had also expressed a positive impact on the changed parameters of cellular immunity and cytokine links. At the same time, 80% of patients after basic treatment is established the predominance of Th2 type immune response, indicating a high risk of developing chronic course of EBV-mononucleosis.

1. Uchaykin V.F. [The guide to infectious diseases at children]. — M.: GEOTAR-MEDITSINA, 2004. — 824 p. (In Russ.)

2. Infectious diseases at children: The textbook for pediatric faculties of medical schools] / Under the editorship of the prof. V.N. Timchenko. — SPb.: Special litas, 2012. — 623 p. (In Russ.)

3. Bokovoj A.G., Egorov A.I. [Herpesvirus infections in children and parents]. — M.: Centr strategicheskoj konjunktury, 2014. — 256 p. (In Russ.)

4. Hmilevskaya S.A., Zaytseva I.A., Zryachkin N.I., Berezhnova I.A. [Features of a condition of system of a hemostasis and immunopathological reactions at Epstein-Barre of a viral infection at children] // The Magazine of Infektologiya, 2015; V. 7, 2: 142—145. (In Russ.)

5. [Human herpesviruses] / Ed. by A. Arvin, G. Campadelli-Fiume, E. Mocarski et al. Cambrige, Cambrige University Press, 2007. http //www.ncbi.nlm.nih.gov/books/NBK/47376.

6. Hmilevskaya S.A. [Epstein-Barre virus mononucleosis clinical and dynamic features of various options of an infection] // Saratov Scientific and Medical Magazine, 2010; V. 6, 3: 561—565. (In Russ.)

7. Kudin A.P. [This «harmless» Epstein-Barr virus infection. Part 2. Acute EBV infection: epidemiology, clinical features, diagnosis, treatment] // Medicinskie Novosti, 2006; 8: 25—31. (In Russ.)

8. Harlamova F.S., Egorova N.Ju., Guseva L.N. [Viruses herpes family and immunity] // Detskie Infekcii, 2006; 3: 3—9 (In Russ.)

9. Simovanyan E.N., Denisenko V.B., Grigorian A.V., Kim M.A. et al. [Epstein-Barr virus infection in children: improving the diagnosis and treatment programs for children] // Detskie Infekcii, 2016; V. 15, 1: 15—24. (In Russ.)

10. Guseva L.N., Egorova N.Ju., Guseva N.A., Fomicheva E.A. et al. [Treatment of Epstein-Barr virus mononucleosis in children at the modern stage] // Detskie Infekcii, 2010; 3: 57—60. (In Russ.)

11. Hmilevskaya S.A., Zaytseva I.A. [Using immunotropic preparations in the treatment of patients with reactivation of Epstein-Barr virus infection, occurring in the form of mononucleosis] // Messenger of New Medical Technologies, 2010; Т.17, 3: 142—145. (In Russ.)